<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35478453</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-9546</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Purinergic signalling</Title><ISOAbbreviation>Purinergic Signal</ISOAbbreviation></Journal><ArticleTitle>P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons.</ArticleTitle><Pagination><StartPage>451</StartPage><EndPage>467</EndPage><MedlinePgn>451-467</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11302-022-09863-5</ELocationID><Abstract><AbstractText>Mutant superoxide dismutase 1 (SOD1) can be constitutively released from motor neurons and transmitted to na&#xef;ve motor neurons to promote the progression of amyotrophic lateral sclerosis (ALS). However, the biological impacts of this process and the precise mechanisms of SOD1 release remain to be fully resolved. Using biochemical and fluorescent techniques, this study aimed to determine if P2X7 receptor activation could induce mutant SOD1 release from motor neurons and whether this released SOD1 could be transmitted to motor neurons or microglia to mediate effects associated with neurodegeneration in ALS. Aggregated SOD1<sup>G93A</sup>, released from murine NSC-34 motor neurons transiently transfected with SOD1<sup>G93A</sup>, could be transmitted to na&#xef;ve NSC-34 cells and murine EOC13 microglia to induce endoplasmic reticulum (ER) stress and tumour necrosis factor-alpha (TNF&#x3b1;) release, respectively. Immunoblotting revealed NSC-34 cells expressed P2X7. Extracellular ATP induced cation dye uptake into these cells, which was blocked by the P2X7 antagonist AZ10606120, demonstrating these cells express functional P2X7. Moreover, ATP induced the rapid release of aggregated SOD1<sup>G93A</sup> from NSC-34 cells transiently transfected with SOD1<sup>G93A</sup>, a process blocked by AZ10606120 and revealing a role for P2X7 in this process. ATP-induced SOD1<sup>G93A</sup> release coincided with membrane blebbing. Finally, aggregated SOD1<sup>G93A</sup> released via P2X7 activation could also be transmitted to NSC-34 and EOC13 cells to induce ER stress and TNF&#x3b1; release, respectively. Collectively, these results identify a novel role for P2X7 in the prion-like propagation of SOD1 in ALS and provide a possible explanation for the therapeutic benefits of P2X7 antagonism previously observed in ALS SOD1<sup>G93A</sup> mice.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bartlett</LastName><ForeName>Rachael</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9199-1326</Identifier><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ly</LastName><ForeName>Diane</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8454-1810</Identifier><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cashman</LastName><ForeName>Neil R</ForeName><Initials>NR</Initials><Identifier Source="ORCID">0000-0002-0080-1006</Identifier><AffiliationInfo><Affiliation>Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sluyter</LastName><ForeName>Ronald</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4909-686X</Identifier><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia. rsluyter@uow.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia. rsluyter@uow.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yerbury</LastName><ForeName>Justin J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0003-2528-7039</Identifier><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Wollongong, NSW, 2522, Australia. jyerbury@uow.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, 2522, Australia. jyerbury@uow.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Purinergic Signal</MedlineTA><NlmUniqueID>101250499</NlmUniqueID><ISSNLinking>1573-9538</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8L70Q75FXE</RegistryNumber><NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000602458">AZ10606120</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058486">Receptors, Purinergic P2X7</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C546469">P2rx7 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058486" MajorTopicYN="Y">Receptors, Purinergic P2X7</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="Y">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Glia</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">Protein aggregation</Keyword><Keyword MajorTopicYN="N">Protein misfolding</Keyword><Keyword MajorTopicYN="N">Purinergic receptor</Keyword></KeywordList><CoiStatement>Rachael Bartlett declares no conflict of interest. Diane Ly declares no conflict of interest. Neil R. Cashman declares no conflict of interest. Ronald Sluyter declares no conflict of interest. Justin J. Yerbury declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35478453</ArticleId><ArticleId IdType="pmc">PMC9832181</ArticleId><ArticleId IdType="doi">10.1007/s11302-022-09863-5</ArticleId><ArticleId IdType="pii">10.1007/s11302-022-09863-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Rouleau GA, Ravits J, Cashman NR (2017) Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med 7:a024117. 10.1101/cshperspect.a024117</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5538408</ArticleId><ArticleId IdType="pubmed">28003278</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, Plotkin SS, Yerbury JJ, Cashman NR. Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:262. doi: 10.3389/fnmol.2019.00262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00262</ArticleId><ArticleId IdType="pmc">PMC6838634</ArticleId><ArticleId IdType="pubmed">31736708</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, Yerbury JJ, Cashman NR. The prion-like nature of amyotrophic lateral sclerosis. Prog Mol Biol Transl Sci. 2020;175:261&#x2013;296. doi: 10.1016/bs.pmbts.2020.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmbts.2020.07.002</ArticleId><ArticleId IdType="pubmed">32958236</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur SJ, McKeown SR, Rashid S. Mutant SOD1 mediated pathogenesis of amyotrophic lateral sclerosis. Gene. 2016;577:109&#x2013;118. doi: 10.1016/j.gene.2015.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.11.049</ArticleId><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C, O'Brien J, Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A. 2011;108:3548&#x2013;3553. doi: 10.1073/pnas.1017275108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017275108</ArticleId><ArticleId IdType="pmc">PMC3048161</ArticleId><ArticleId IdType="pubmed">21321227</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Guest WC, Yanai A, Pokrishevsky E, O'Neill MA, Gibbs E, Semenchenko V, Yousefi M, Wishart DS, Plotkin SS, Cashman NR. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc Natl Acad Sci U S A. 2011;108:16398&#x2013;16403. doi: 10.1073/pnas.1102645108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102645108</ArticleId><ArticleId IdType="pmc">PMC3182705</ArticleId><ArticleId IdType="pubmed">21930926</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O'Neill MA, Yanai A, Silverman JM, Zeineddine R, Corcoran L, Kumita JR, Luheshi LM, Yousefi M, Coleman BM, Hill AF, Plotkin SS, Mackenzie IR, Cashman NR. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A. 2014;111:3620&#x2013;3625. doi: 10.1073/pnas.1312245111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeineddine R, Pundavela JF, Corcoran L, Stewart EM, Do-Ha D, Bax M, Guillemin G, Vine KL, Hatters DM, Ecroyd H, Dobson CM, Turner BJ, Ooi L, Wilson MR, Cashman NR, Yerbury JJ. SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation. Mol Neurodegener. 2015;10:57. doi: 10.1186/s13024-015-0053-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-015-0053-4</ArticleId><ArticleId IdType="pmc">PMC4628302</ArticleId><ArticleId IdType="pubmed">26520394</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Diamond J, Sari A, Fromholt S, Galaleldeen A, Ostrow LW, Glass JD, Hart PJ, Borchelt DR. Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS. Acta Neuropathol. 2016;132:827&#x2013;840. doi: 10.1007/s00401-016-1623-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1623-4</ArticleId><ArticleId IdType="pmc">PMC5107152</ArticleId><ArticleId IdType="pubmed">27704280</ArticleId></ArticleIdList></Reference><Reference><Citation>Crown A, McAlary L, Fagerli E, Brown H, Yerbury JJ, Galaleldeen A, Cashman NR, Borchelt DR, Ayers JI. Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection. PLoS ONE. 2020;15:e0227655. doi: 10.1371/journal.pone.0227655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0227655</ArticleId><ArticleId IdType="pmc">PMC6991973</ArticleId><ArticleId IdType="pubmed">31999698</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Fromholt S, Koch M, DeBosier A, McMahon B, Xu G, Borchelt DR. Experimental transmissibility of mutant SOD1 motor neuron disease. Acta Neuropathol. 2014;128:791&#x2013;803. doi: 10.1007/s00401-014-1342-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1342-7</ArticleId><ArticleId IdType="pubmed">25262000</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C, Keller S, Altevogt P, Costa J. Evidence for secretion of Cu, Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci Lett. 2007;428:43&#x2013;46. doi: 10.1016/j.neulet.2007.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2007.09.024</ArticleId><ArticleId IdType="pubmed">17942226</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaramoorthy V, Walker AK, Yerbury J, Soo KY, Farg MA, Hoang V, Zeineddine R, Spencer D, Atkin JD. Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells. Cell Mol Life Sci. 2013;70:4181&#x2013;4195. doi: 10.1007/s00018-013-1385-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1385-2</ArticleId><ArticleId IdType="pubmed">23765103</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts K, Zeineddine R, Corcoran L, Li W, Campbell IL, Yerbury JJ. Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype. Glia. 2013;61:409&#x2013;419. doi: 10.1002/glia.22444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22444</ArticleId><ArticleId IdType="pubmed">23281114</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang LH, Caseley EA, Muench SP, Roger S. Structural basis for the functional properties of the P2X7 receptor for extracellular ATP. Purinergic Signal. 2021;17:331&#x2013;344. doi: 10.1007/s11302-021-09790-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-021-09790-x</ArticleId><ArticleId IdType="pmc">PMC8410900</ArticleId><ArticleId IdType="pubmed">33987781</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluyter R. The P2X7 Receptor. Adv Exp Med Biol. 2017;1051:17&#x2013;53. doi: 10.1007/5584_2017_59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/5584_2017_59</ArticleId><ArticleId IdType="pubmed">28676924</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrejew R, Oliveira-Giacomelli &#xc1;, Ribeiro DE, Glaser T, Arnaud-Sampaio VF, Lameu C, Ulrich H. The P2X7 receptor: central hub of brain diseases. Front Mol Neurosci. 2020;13:124. doi: 10.3389/fnmol.2020.00124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00124</ArticleId><ArticleId IdType="pmc">PMC7413029</ArticleId><ArticleId IdType="pubmed">32848594</ArticleId></ArticleIdList></Reference><Reference><Citation>Territo PR, Zarrinmayeh H. P2X7 receptors in neurodegeneration: potential therapeutic applications from basic to clinical approaches. Front Cell Neurosci. 2021;15:617036. doi: 10.3389/fncel.2021.617036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.617036</ArticleId><ArticleId IdType="pmc">PMC8055960</ArticleId><ArticleId IdType="pubmed">33889073</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Ruiz C, Calzaferri F, Garc&#xed;a AG. P2X7 receptor antagonism as a potential therapy in amyotrophic lateral sclerosis. Front Mol Neurosci. 2020;13:93. doi: 10.3389/fnmol.2020.00093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00093</ArticleId><ArticleId IdType="pmc">PMC7303288</ArticleId><ArticleId IdType="pubmed">32595451</ArticleId></ArticleIdList></Reference><Reference><Citation>Volont&#xe9; C, Amadio S, Liguori F, Fabbrizio P. Duality of P2X7 receptor in amyotrophic lateral sclerosis. Front Pharmacol. 2020;11:1148. doi: 10.3389/fphar.2020.01148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.01148</ArticleId><ArticleId IdType="pmc">PMC7394054</ArticleId><ArticleId IdType="pubmed">32792962</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S, Amadio S, Parisi C, Matteucci A, Potenza RL, Armida M, Popoli P, D'Ambrosi N, Volont&#xe9; C. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis. Dis Model Mech. 2014;7:1101&#x2013;1109. doi: 10.1242/dmm.017038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.017038</ArticleId><ArticleId IdType="pmc">PMC4142730</ArticleId><ArticleId IdType="pubmed">25038061</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartlett R, Sluyter V, Watson D, Sluyter R, Yerbury JJ. P2X7 antagonism using Brilliant Blue G reduces body weight loss and prolongs survival in female SOD1(G93A) amyotrophic lateral sclerosis mice. PeerJ. 2017;5:e3064. doi: 10.7717/peerj.3064.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.3064</ArticleId><ArticleId IdType="pmc">PMC5335685</ArticleId><ArticleId IdType="pubmed">28265522</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervetto C, Frattaroli D, Maura G, Marcoli M. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism. Toxicology. 2013;311:69&#x2013;77. doi: 10.1016/j.tox.2013.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2013.04.004</ArticleId><ArticleId IdType="pubmed">23583883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Ruiz C, Garc&#xed;a-Magro N, Negredo P, Avenda&#xf1;o C, Bhattacharya A, Ceusters M, Garc&#xed;a AG (2020) Chronic administration of P2X7 receptor antagonist JNJ-47965567 delays disease onset and progression, and improves motor performance in ALS SOD1(G93A) female mice. Dis Model Mech 13:dmm045732. 10.1242/dmm.045732</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7648608</ArticleId><ArticleId IdType="pubmed">33174532</ArticleId></ArticleIdList></Reference><Reference><Citation>de Torre-Minguela C, Barber&#xe0;-Cremades M, G&#xf3;mez AI, Mart&#xed;n-S&#xe1;nchez F, Pelegr&#xed;n P. Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process. Sci Rep. 2016;6:22586. doi: 10.1038/srep22586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep22586</ArticleId><ArticleId IdType="pmc">PMC4776275</ArticleId><ArticleId IdType="pubmed">26935289</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupovac A, Geraghty NJ, Watson D, Sluyter R. Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells. Immunol Cell Biol. 2015;93:77&#x2013;85. doi: 10.1038/icb.2014.69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2014.69</ArticleId><ArticleId IdType="pubmed">25155463</ArticleId></ArticleIdList></Reference><Reference><Citation>Takenouchi T, Tsukimoto M, Iwamaru Y, Sugama S, Sekiyama K, Sato M, Kojima S, Hashimoto M, Kitani H. Extracellular ATP induces unconventional release of glyceraldehyde-3-phosphate dehydrogenase from microglial cells. Immunol Lett. 2015;167:116&#x2013;124. doi: 10.1016/j.imlet.2015.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2015.08.002</ArticleId><ArticleId IdType="pubmed">26277554</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishida K, Nakatani T, Ohishi A, Okuda H, Higashi Y, Matsuo T, Fujimoto S, Nagasawa K. Mitochondrial dysfunction is involved in P2X7 receptor-mediated neuronal cell death. J Neurochem. 2012;122:1118&#x2013;1128. doi: 10.1111/j.1471-4159.2012.07868.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2012.07868.x</ArticleId><ArticleId IdType="pubmed">22774935</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, Dahrouge S, Antel JP. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn. 1992;194:209&#x2013;221. doi: 10.1002/aja.1001940306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1001940306</ArticleId><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, Atkin JD, Farg MA, Zang DW, Rembach A, Lopes EC, Patch JD, Hill AF, Cheema SS. Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J Neurosci. 2005;25:108&#x2013;117. doi: 10.1523/jneurosci.4253-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.4253-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725218</ArticleId><ArticleId IdType="pubmed">15634772</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartlett R, Yerbury JJ, Sluyter R. P2X7 receptor activation induces reactive oxygen species formation and cell death in murine EOC13 microglia. Mediators Inflamm. 2013;2013:271813. doi: 10.1155/2013/271813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/271813</ArticleId><ArticleId IdType="pmc">PMC3568910</ArticleId><ArticleId IdType="pubmed">23431238</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671&#x2013;675. doi: 10.1038/nmeth.2089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwawaki T, Akai R, Kohno K, Miura M. A transgenic mouse model for monitoring endoplasmic reticulum stress. Nat Med. 2004;10:98&#x2013;102. doi: 10.1038/nm970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm970</ArticleId><ArticleId IdType="pubmed">14702639</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E, McAlary L, Farrawell NE, Zhao B, Sher M, Yerbury JJ, Cashman NR. Tryptophan 32-mediated SOD1 aggregation is attenuated by pyrimidine-like compounds in living cells. Sci Rep. 2018;8:15590. doi: 10.1038/s41598-018-32835-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-32835-y</ArticleId><ArticleId IdType="pmc">PMC6197196</ArticleId><ArticleId IdType="pubmed">30349065</ArticleId></ArticleIdList></Reference><Reference><Citation>Keilhoff G, Lucas B, Uhde K, Fansa H. Selected gene profiles of stressed NSC-34 cells and rat spinal cord following peripheral nerve reconstruction and minocycline treatment. Exp Ther Med. 2016;11:1685&#x2013;1699. doi: 10.3892/etm.2016.3130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2016.3130</ArticleId><ArticleId IdType="pmc">PMC4840837</ArticleId><ArticleId IdType="pubmed">27168790</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco MC, Ye Y, Refakis CA, Feldman JL, Stokes AL, Basso M, Fern&#xe1;ndez M, de Mera RM, Sparrow NA, Calingasan NY, Kiaei M, Rhoads TW, Ma TC, Grumet M, Barnes S, Beal MF, Beckman JS, Mehl R, Est&#xe9;vez AG. Nitration of Hsp90 induces cell death. Proc Natl Acad Sci U S A. 2013;110:E1102&#x2013;1111. doi: 10.1073/pnas.1215177110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1215177110</ArticleId><ArticleId IdType="pmc">PMC3607042</ArticleId><ArticleId IdType="pubmed">23487751</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandelman M, Levy M, Cassina P, Barbeito L, Beckman JS. P2X7 receptor-induced death of motor neurons by a peroxynitrite/FAS-dependent pathway. J Neurochem. 2013;126:382&#x2013;388. doi: 10.1111/jnc.12286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12286</ArticleId><ArticleId IdType="pmc">PMC3716845</ArticleId><ArticleId IdType="pubmed">23646980</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskaracharya A, Dao-Ung P, Jalilian I, Spildrejorde M, Skarratt KK, Fuller SJ, Sluyter R, Stokes L. Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism. PLoS ONE. 2014;9:e93058. doi: 10.1371/journal.pone.0093058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093058</ArticleId><ArticleId IdType="pmc">PMC3966854</ArticleId><ArticleId IdType="pubmed">24671093</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel AD, Chambers LJ, Clay WC, Condreay JP, Walter DS, Chessell IP. Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding. Br J Pharmacol. 2007;151:103&#x2013;114. doi: 10.1038/sj.bjp.0707196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0707196</ArticleId><ArticleId IdType="pmc">PMC2012979</ArticleId><ArticleId IdType="pubmed">17339830</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidula S, Dhuna K, Helliwell R, Stokes L. Positive allosteric modulation of P2X7 promotes apoptotic cell death over lytic cell death responses in macrophages. Cell Death Dis. 2019;10:882. doi: 10.1038/s41419-019-2110-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-2110-3</ArticleId><ArticleId IdType="pmc">PMC6877589</ArticleId><ArticleId IdType="pubmed">31767863</ArticleId></ArticleIdList></Reference><Reference><Citation>Panupinthu N, Zhao L, Possmayer F, Ke HZ, Sims SM, Dixon SJ. P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid. J Biol Chem. 2007;282:3403&#x2013;3412. doi: 10.1074/jbc.M605620200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M605620200</ArticleId><ArticleId IdType="pubmed">17135244</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhoef PA, Estacion M, Schilling W, Dubyak GR. P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release. J Immunol. 2003;170:5728&#x2013;5738. doi: 10.4049/jimmunol.170.11.5728.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.11.5728</ArticleId><ArticleId IdType="pubmed">12759456</ArticleId></ArticleIdList></Reference><Reference><Citation>Virginio C, MacKenzie A, North RA, Surprenant A. Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J Physiol. 1999;519(Pt 2):335&#x2013;346. doi: 10.1111/j.1469-7793.1999.0335m.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.1999.0335m.x</ArticleId><ArticleId IdType="pmc">PMC2269518</ArticleId><ArticleId IdType="pubmed">10457053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirov A, Al-Hashimi H, Solomon P, Mazur C, Thorpe PE, Sims PJ, Tarantini F, Kumar TK, Prudovsky I. Phosphatidylserine externalization and membrane blebbing are involved in the nonclassical export of FGF1. J Cell Biochem. 2012;113:956&#x2013;966. doi: 10.1002/jcb.23425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.23425</ArticleId><ArticleId IdType="pmc">PMC3264788</ArticleId><ArticleId IdType="pubmed">22034063</ArticleId></ArticleIdList></Reference><Reference><Citation>Allsopp RC, Dayl S, Schmid R, Evans RJ. Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120. Sci Rep. 2017;7:725. doi: 10.1038/s41598-017-00732-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00732-5</ArticleId><ArticleId IdType="pmc">PMC5429621</ArticleId><ArticleId IdType="pubmed">28389651</ArticleId></ArticleIdList></Reference><Reference><Citation>Karasawa A, Kawate T (2016) Structural basis for subtype-specific inhibition of the P2X7 receptor. eLife 5:e22153. 10.7554/eLife.22153</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5176352</ArticleId><ArticleId IdType="pubmed">27935479</ArticleId></ArticleIdList></Reference><Reference><Citation>Illes P, M&#xfc;ller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, King BF, Di Virgilio F. Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. Br J Pharmacol. 2021;178:489&#x2013;514. doi: 10.1111/bph.15299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15299</ArticleId><ArticleId IdType="pmc">PMC8199792</ArticleId><ArticleId IdType="pubmed">33125712</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman JM, Fernando SM, Grad LI, Hill AF, Turner BJ, Yerbury JJ, Cashman NR. Disease mechanisms in ALS: misfolded SOD1 transferred through exosome-dependent and exosome-independent pathways. Cell Mol Neurobiol. 2016;36:377&#x2013;381. doi: 10.1007/s10571-015-0294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-015-0294-3</ArticleId><ArticleId IdType="pubmed">26908139</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ambrosi N, Finocchi P, Apolloni S, Cozzolino M, Ferri A, Padovano V, Pietrini G, Carr&#xec; MT, Volont&#xe9; C. The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. J Immunol. 2009;183:4648&#x2013;4656. doi: 10.4049/jimmunol.0901212.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901212</ArticleId><ArticleId IdType="pubmed">19734218</ArticleId></ArticleIdList></Reference><Reference><Citation>Ousingsawat J, Wanitchakool P, Kmit A, Romao AM, Jantarajit W, Schreiber R, Kunzelmann K. Anoctamin 6 mediates effects essential for innate immunity downstream of P2X7 receptors in macrophages. Nat Commun. 2015;6:6245. doi: 10.1038/ncomms7245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7245</ArticleId><ArticleId IdType="pubmed">25651887</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie AB, Young MT, Adinolfi E, Surprenant A. Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. J Biol Chem. 2005;280:33968&#x2013;33976. doi: 10.1074/jbc.M502705200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M502705200</ArticleId><ArticleId IdType="pubmed">15994333</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Chiozzi P, Chiesa A, Ferrari D, Sanz JM, Falzoni S, Pinton P, Rizzuto R, Olson MF, Di Virgilio F. Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells. Mol Biol Cell. 2003;14:2655&#x2013;2664. doi: 10.1091/mbc.02-04-0061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.02-04-0061</ArticleId><ArticleId IdType="pmc">PMC165666</ArticleId><ArticleId IdType="pubmed">12857854</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S, Fabbrizio P, Amadio S, Napoli G, Freschi M, Sironi F, Pevarello P, Tarroni P, Liberati C, Bendotti C, Volont&#xe9; C (2021) Novel P2X7 antagonist ameliorates the early phase of ALS disease and decreases inflammation and autophagy in SOD1-G93A mouse model. Int J Mol Sci 22:10649. 10.3390/ijms221910649</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8508678</ArticleId><ArticleId IdType="pubmed">34638992</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbrizio P, Amadio S, Apolloni S, Volont&#xe9; C. P2X7 receptor activation modulates autophagy in SOD1-G93A mouse microglia. Front Cell Neurosci. 2017;11:249. doi: 10.3389/fncel.2017.00249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00249</ArticleId><ArticleId IdType="pmc">PMC5566572</ArticleId><ArticleId IdType="pubmed">28871219</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt DR, Guarnieri M, Wong PC, Lee MK, Slunt HS, Xu ZS, Sisodia SS, Price DL, Cleveland DW. Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J Biol Chem. 1995;270:3234&#x2013;3238. doi: 10.1074/jbc.270.7.3234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.7.3234</ArticleId><ArticleId IdType="pubmed">7852409</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisp MJ, Mawuenyega KG, Patterson BW, Reddy NC, Chott R, Self WK, Weihl CC, Jockel-Balsarotti J, Varadhachary AS, Bucelli RC, Yarasheski KE, Bateman RJ, Miller TM. In vivo kinetic approach reveals slow SOD1 turnover in the CNS. J Clin Invest. 2015;125:2772&#x2013;2780. doi: 10.1172/jci80705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci80705</ArticleId><ArticleId IdType="pmc">PMC4563686</ArticleId><ArticleId IdType="pubmed">26075819</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubyak GR. P2X7 receptor regulation of non-classical secretion from immune effector cells. Cell Microbiol. 2012;14:1697&#x2013;1706. doi: 10.1111/cmi.12001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12001</ArticleId><ArticleId IdType="pmc">PMC3473166</ArticleId><ArticleId IdType="pubmed">22882764</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi ME, Marrone L, Azzouz M, Trotti D. Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis. EMBO J. 2021;40:e106389. doi: 10.15252/embj.2020106389.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106389</ArticleId><ArticleId IdType="pmc">PMC8126909</ArticleId><ArticleId IdType="pubmed">33792056</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozas P, Bargsted L, Mart&#xed;nez F, Hetz C, Medinas DB. The ER proteostasis network in ALS: Determining the differential motoneuron vulnerability. Neurosci Lett. 2017;636:9&#x2013;15. doi: 10.1016/j.neulet.2016.04.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.04.066</ArticleId><ArticleId IdType="pubmed">27150076</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Cabuy E, Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci. 2009;12:627&#x2013;636. doi: 10.1038/nn.2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2297</ArticleId><ArticleId IdType="pubmed">19330001</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortarolo M, Lo Coco D, Veglianese P, Vallarola A, Giordana MT, Marcon G, Beghi E, Poloni M, Strong MJ, Iyer AM, Aronica E, Bendotti C. Amyotrophic lateral sclerosis, a multisystem pathology: insights into the role of TNF&#x3b1;. Mediators Inflamm. 2017;2017:2985051. doi: 10.1155/2017/2985051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/2985051</ArticleId><ArticleId IdType="pmc">PMC5610855</ArticleId><ArticleId IdType="pubmed">29081600</ArticleId></ArticleIdList></Reference><Reference><Citation>Illes P, Khan TM, Rubini P. Neuronal P2X7 receptors revisited: do they really exist? J Neurosci. 2017;37:7049&#x2013;7062. doi: 10.1523/jneurosci.3103-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.3103-16.2017</ArticleId><ArticleId IdType="pmc">PMC6705732</ArticleId><ArticleId IdType="pubmed">28747388</ArticleId></ArticleIdList></Reference><Reference><Citation>Miras-Portugal MT, Sebasti&#xe1;n-Serrano &#xc1;, de Diego GL, D&#xed;az-Hern&#xe1;ndez M. Neuronal P2X7 receptor: involvement in neuronal physiology and pathology. J Neurosci. 2017;37:7063&#x2013;7072. doi: 10.1523/jneurosci.3104-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.3104-16.2017</ArticleId><ArticleId IdType="pmc">PMC6705729</ArticleId><ArticleId IdType="pubmed">28747389</ArticleId></ArticleIdList></Reference><Reference><Citation>Moores TS, Hasdemir B, Vega-Riveroll L, Deuchars J, Parson SH. Properties of presynaptic P2X7-like receptors at the neuromuscular junction. Brain Res. 2005;1034:40&#x2013;50. doi: 10.1016/j.brainres.2004.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2004.12.001</ArticleId><ArticleId IdType="pubmed">15713258</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Ugawa S, Ueda T, Ishida Y, Inoue K, Kyaw Nyunt A, Umemura A, Mase M, Yamada K, Shimada S. Cellular localization of P2X7 receptor mRNA in the rat brain. Brain Res. 2008;1194:45&#x2013;55. doi: 10.1016/j.brainres.2007.11.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.11.064</ArticleId><ArticleId IdType="pubmed">18177631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiho H, Matsuoka I, Kimura J, Nakanishi H. Identification of P2X7 (P2Z) receptor in N18TG-2 cells and NG108-15 cells. J Neurochem. 1998;70:951&#x2013;957. doi: 10.1046/j.1471-4159.1998.70030951.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1998.70030951.x</ArticleId><ArticleId IdType="pubmed">9489714</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly D, Dongol A, Cuthbertson P, Guy TV, Geraghty NJ, Sophocleous RA, Sin L, Turner BJ, Watson D, Yerbury JJ, Sluyter R. The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1(G93A) mice. Purinergic Signal. 2020;16:109&#x2013;122. doi: 10.1007/s11302-020-09692-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-020-09692-4</ArticleId><ArticleId IdType="pmc">PMC7166237</ArticleId><ArticleId IdType="pubmed">32170537</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluyter R, Bartlett R, Ly D, Yerbury JJ. P2X7 receptor antagonism in amyotrophic lateral sclerosis. Neural Regen Res. 2017;12:749&#x2013;750. doi: 10.4103/1673-5374.206643.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.206643</ArticleId><ArticleId IdType="pmc">PMC5461610</ArticleId><ArticleId IdType="pubmed">28616029</ArticleId></ArticleIdList></Reference><Reference><Citation>Adriouch S, Dox C, Welge V, Seman M, Koch-Nolte F, Haag F. Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J Immunol. 2002;169:4108&#x2013;4112. doi: 10.4049/jimmunol.169.8.4108.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.169.8.4108</ArticleId><ArticleId IdType="pubmed">12370338</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartlett R, Stokes L, Sluyter R. The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol Rev. 2014;66:638&#x2013;675. doi: 10.1124/pr.113.008003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.113.008003</ArticleId><ArticleId IdType="pubmed">24928329</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker WS, Gatewood J, Olivas E, Askew D, Havenith CE. Mouse microglial cell lines differing in constitutive and interferon-gamma-inducible antigen-presenting activities for naive and memory CD4+ and CD8+ T cells. J Neuroimmunol. 1995;63:163&#x2013;174. doi: 10.1016/0165-5728(95)00146-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-5728(95)00146-8</ArticleId><ArticleId IdType="pubmed">8550814</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorge RE, Trang T, Dorfman R, Smith SB, Beggs S, Ritchie J, Austin JS, Zaykin DV, Vander Meulen H, Costigan M, Herbert TA, Yarkoni-Abitbul M, Tichauer D, Livneh J, Gershon E, Zheng M, Tan K, John SL, Slade GD, Jordan J, Woolf CJ, Peltz G, Maixner W, Diatchenko L, Seltzer Z, Salter MW, Mogil JS. Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med. 2012;18:595&#x2013;599. doi: 10.1038/nm.2710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2710</ArticleId><ArticleId IdType="pmc">PMC3350463</ArticleId><ArticleId IdType="pubmed">22447075</ArticleId></ArticleIdList></Reference><Reference><Citation>Augusti-Tocco G, Sato G. Establishment of functional clonal lines of neurons from mouse neuroblastoma. Proc Natl Acad Sci U S A. 1969;64:311&#x2013;315. doi: 10.1073/pnas.64.1.311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.64.1.311</ArticleId><ArticleId IdType="pmc">PMC286163</ArticleId><ArticleId IdType="pubmed">5263016</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy ED (1966) Characteristic Tumours. In: Green EL (ed) Biology of the Laboratory Mouse. Dover Publications, Inc., New York, Ch 27. http://www.informatics.jax.org/greenbook/frames/frame27.shtml</Citation></Reference><Reference><Citation>Donnelly-Roberts DL, Namovic MT, Han P, Jarvis MF. Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br J Pharmacol. 2009;157:1203&#x2013;1214. doi: 10.1111/j.1476-5381.2009.00233.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2009.00233.x</ArticleId><ArticleId IdType="pmc">PMC2743839</ArticleId><ArticleId IdType="pubmed">19558545</ArticleId></ArticleIdList></Reference><Reference><Citation>Young MT, Pelegrin P, Surprenant A. Identification of Thr283 as a key determinant of P2X7 receptor function. Br J Pharmacol. 2006;149:261&#x2013;268. doi: 10.1038/sj.bjp.0706880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0706880</ArticleId><ArticleId IdType="pmc">PMC2014266</ArticleId><ArticleId IdType="pubmed">16940988</ArticleId></ArticleIdList></Reference><Reference><Citation>Chessell IP, Simon J, Hibell AD, Michel AD, Barnard EA, Humphrey PP. Cloning and functional characterisation of the mouse P2X7 receptor. FEBS Lett. 1998;439:26&#x2013;30. doi: 10.1016/s0014-5793(98)01332-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0014-5793(98)01332-5</ArticleId><ArticleId IdType="pubmed">9849870</ArticleId></ArticleIdList></Reference><Reference><Citation>Beamer E, Kuchukulla M, Boison D, Engel T. ATP and adenosine-two players in the control of seizures and epilepsy development. Prog Neurobiol. 2021;204:102105. doi: 10.1016/j.pneurobio.2021.102105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2021.102105</ArticleId><ArticleId IdType="pubmed">34144123</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S, Cunha C, Barbosa M, Vaz AR, Brites D. Exosomes from NSC-34 Cells Transfected with hSOD1-G93A Are Enriched in miR-124 and Drive Alterations in Microglia Phenotype. Front Neurosci. 2017;11:273. doi: 10.3389/fnins.2017.00273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00273</ArticleId><ArticleId IdType="pmc">PMC5434170</ArticleId><ArticleId IdType="pubmed">28567000</ArticleId></ArticleIdList></Reference><Reference><Citation>Malada Edelstein YF, Solomonov Y, Hadad N, Alfahel L, Israelson A, Levy R. Early upregulation of cytosolic phospholipase A2&#x3b1; in motor neurons is induced by misfolded SOD1 in a mouse model of amyotrophic lateral sclerosis. J Neuroinflammation. 2021;18:274. doi: 10.1186/s12974-021-02326-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02326-5</ArticleId><ArticleId IdType="pmc">PMC8620709</ArticleId><ArticleId IdType="pubmed">34823547</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>